远大医药(00512)全球创新的血管内双模成像系统 NOVASYNC 获药监局批准于中国上市GRANDPHARMA (00512) has received approval from the drug administration for the innovative intravascular dual-mode imaging system, NOVASYNC, to be launched in China.
[Significant Events]
Little Garden (00999) plans to globally issue approximately 0.1012 billion shares at a price of 8.5 Hong Kong dollars per share.
GRANDPHARMA (00512) Global innovative intravascular dual-mode imaging system NOVASYNC has been approved by the Drug Administration for market launch in China.
Connat Optical (02276) plans to acquire ownership of a piece of land in a technology park in Thailand for 0.24 billion Thai baht.
[Earnings Reports Data]
PICC GROUP (01339) reported that the original insurance premium income for the first 11 months was 646.933 billion yuan, an increase of 5.5% year-on-year.
In the first 11 months, PICC P&C (02328) had original insurance premium income of 496.845 billion yuan, a year-on-year increase of 5.1%.
In November, CHINA RES LAND (01109) had a total contract sales amount of approximately 25.8 billion yuan, a year-on-year increase of 6.9%.
[Repurchase and Cancellation]
On December 12, TENCENT (00700) spent approximately 0.704 billion Hong Kong dollars to buy back 1.69 million shares.
On December 11, Alibaba-W (09988) spent 9.995 million US dollars to buy back 0.904 million shares.
On December 12, AIA (01299) spent 61.7113 million Hong Kong dollars to buy back 1.0674 million shares.
For more details, please refer to 智通财经网().
